Reproductive Health Complicated by Substance Use | Medication for OUD and Intrapartum Pain Control

Presenter: Farzad Kamyar MD, MBA, Director of Collaborative Care MOTHER program at High-Risk Pregnancy Center, Psychiatry and Addiction Medicine

Online CME Credit

Fee: $50.00

Provides 1.00 hour(s) of CE/CME credit (Presented on July 14, 2021; Reviewed June 20, 2023; Expires August 6, 2024)


This series will provide information surrounding reproductive health (pregnancy) and substance use. It aims to summarize best practices, guidelines, and protocols for medical professionals involved in the care of pregnant patients with Substance Use Disorder (SUD) or more specifically Opioid Use Disorder (OUD). The goal is to help improve the identification and treatment of SUD, identification, and treatment for the infant(s), reproductive planning, and care coordination to decrease parental and/or neonatal complications before, during, and/or after delivery.

This series is directed toward anyone who interfaces with pregnant and non-pregnant patients of reproductive age. Specifically, medical professionals who are licensed in the state of Nevada, include physicians, nurse practitioners, physician assistants, registered nurses, licensed midwives, lactation consultants, licensed clinical social workers, and case managers. However, this does not preclude others such as government agencies, specialty offices, and first responders from using this as a resource or in various clinical situations where contact with a pregnant patient is made.

Learning Objectives

Following participation in this course, participants should be able to:

  • Discuss addiction as a chronic disease
  • Identify effective treatment for opioid use disorder, which includes the use of medications as part of the standard of care
  • Describe the use of pain control protocols for patients with opioid dependence